Jungwon Woo - Genexine Chief Officer

095700 Stock  KRW 7,130  110.00  1.52%   

Insider

Jungwon Woo is Chief Officer of Genexine
Phone82 3 1628 3200
Webhttps://www.genexine.com

Genexine Management Efficiency

The company has return on total asset (ROA) of (0.0172) % which means that it has lost $0.0172 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (10.0578) %, meaning that it generated substantial loss on money invested by shareholders. Genexine's management efficiency ratios could be used to measure how well Genexine manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 40.79 B in total debt with debt to equity ratio (D/E) of 31.9, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Genexine has a current ratio of 2.21, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Genexine until it has trouble settling it off, either with new capital or with free cash flow. So, Genexine's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Genexine sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Genexine to invest in growth at high rates of return. When we think about Genexine's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

John FogartySK Hynix
N/A
Kyungwhoon CheunSamsung Electronics Co
N/A
DongUn LeeLG Chemicals
N/A
Scott ChangSK Hynix
N/A
Ulf AkerlindSK Hynix
N/A
Ara BaboyanSK Hynix
N/A
JaeYong LeeSamsung Electronics Co
55
JungBae LeeSamsung Electronics Co
56
YoungHyun JunSamsung SDI
63
Hark ParkSamsung Electronics Co
59
Kyehyun KyungSamsung Electronics Co
60
JungBae LeeSamsung Electronics Co
56
JongHee HanSamsung Electronics Co
61
Hyunsuk YoonLG Chemicals
N/A
SangKyun KimSamsung Electronics Co
N/A
John MichaelSK Hynix
N/A
Hark ParkSamsung Electronics Co
59
GeonJoo LeeLG Chemicals
N/A
Kyungwhoon CheunSamsung Electronics Co
N/A
Mathieu DeuvergneSK Hynix
N/A
JaeYong LeeSamsung Electronics Co
55
Genexine, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of immunotherapeutics and long-acting biologics in South Korea. Genexine, Inc. was founded in 1999 and is based in Seongnam, South Korea. Genexine is traded on Korean Securities Dealers Automated Quotations in South Korea. Genexine (095700) is traded on KOSDAQ in Korea and employs 123 people.

Management Performance

Genexine Leadership Team

Elected by the shareholders, the Genexine's board of directors comprises two types of representatives: Genexine inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Genexine. The board's role is to monitor Genexine's management team and ensure that shareholders' interests are well served. Genexine's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Genexine's outside directors are responsible for providing unbiased perspectives on the board's policies.
You Suh, Head Director
Jungwon Woo, Chief Officer
Sung CPA, CFO VP
Kyu Kim, Ex Bus
Jae Park, Ex Operation
Young Sung, Chairman Founder
JaiHyun Kwon, Director Transaction
Sung Lee, Head VP

Genexine Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Genexine a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Genexine. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Complementary Tools for Genexine Stock analysis

When running Genexine's price analysis, check to measure Genexine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genexine is operating at the current time. Most of Genexine's value examination focuses on studying past and present price action to predict the probability of Genexine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genexine's price. Additionally, you may evaluate how the addition of Genexine to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Equity Valuation
Check real value of public entities based on technical and fundamental data
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Please note, there is a significant difference between Genexine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genexine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genexine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.